Dr. Deven Shah is currently the in house Chemistry, Manufacturing, & Control (CM&C) lead in Certara’s Strategic Consulting Division. He has more than 20 years of experience within the Pharmaceutical Industry working across all phases of drug development & multiple routes of administration including oral, topical, parenteral, & transdermal. He has gained significant experience in diverse line functions including CM&C, Due Diligence evaluations, Portfolio/Alliance Management, & Business Development. Deven came to Certara from Noven Pharmaceuticals where he led their Formulation & Process Development organizations in support of bringing novel transdermal products to market for patients in need. Prior to that, He worked at GSK for 16 years and led teams in identifying promising molecules, technology platforms, & promising biotechs for building alliances and enriching the company pipeline. While working with biotech partners at GSK, Deven was instrumental in identifying the critical nonclinical needs of the alliance partners in the areas of CM&C & other line functions and offering internal expertise for risk mitigation leading to a ‘win-win’ collaboration. Several candidate molecules identified by the teams he led have eventually received global approval status. Prior to GSK, Deven spent six years within the preclinical drug evaluation department at the Johnson & Johnson R&D unit in roles of increasing responsibility. Deven received his Ph.D. in Pharmaceutics/Drug Delivery from the University of Southern California. He holds a B.S. in Pharmacy from Kolkata, India.